Jesper Høiland gibes at Eli Lilly CEO: “He is pathetic”

CEO in Radius Health, Danish Jesper Høiland, enjoys competing against Eli Lilly, his old rival from his time in Novo Nordisk. But he does not care much for the rivaling CEO’s view on the rising prices on medicine in the US.

Photo: /Ritzau Scanpix/Niels Ahlmann Olesen/

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Novo Nordisk Fonden køber sig ind i børsen i Israel

Novo Nordisk Fonden er gået med i et syndikat af investorer, som står til at overtage små 40 pct. af børsen i den israelske by Tel Aviv. Det skal bane vejen for, at børsen selv bliver et børsnoteret selskab. Hos Novo Holdings ser man det som "en god langsigtet investering".

Related articles